TLR9 rs5743836, polymorphism may represent a molecular risk factor for B-cell Non-Hodgkin lymphomas (B-NHL) among Egyptian subjects [22]. This evidence concerns the gene TLR9 and B-cell non-Hodgkin lymphoma.